When should you consider allergen immunotherapy?

Rana S. Bonds, J. Andrew Grant, William J. Calhoun

Research output: Contribution to journalReview articlepeer-review


Allergen immunotherapy is recommended for patients with insect venom hypersensitivity and those who have both allergic rhinitis and allergic asthma. Consider immunotherapy for patients whose allergic rhinitis is insufficiently controlled by medication and avoidance measures. A standard immunotherapy schedule entails injections of increasing concentrations of allergens once or twice weekly during a buildup phase. Maintenance dosing is continued for 3 to 5 years. Immunotherapy in patients with allergic rhinitis and/or conjunctivitis attributable to IgE-mediated mechanisms modifies the natural history of the disease, rather than just alleviating symptoms. Immunotherapy for children with allergic rhinitis may prevent asthma and reduce the risk of sensitivity to other allergens.

Original languageEnglish (US)
Pages (from-to)436-440
Number of pages5
JournalJournal of Respiratory Diseases
Issue number10
StatePublished - Oct 2007


  • Allergic asthma
  • Allergic rhinitis
  • Immunotherapy
  • Venom allergy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'When should you consider allergen immunotherapy?'. Together they form a unique fingerprint.

Cite this